Dec 5, 2019
NCT03820817: Phase 1: Rifaximin in Patients With Monoclonal Gammopathy
NCT03820817: Phase 1: Rifaximin in Patients With Monoclonal Gammopathy MGUS Rifaximin in Patients With Monoclonal Gammopathy This trial...
274
top of page
Posts Archive
bottom of page